ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,315Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 302

$1M Total Retail Price of All Prescriptions

Rank: 34 out of 302

543 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

27% of this provider’s 543 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 543 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

4% of this provider’s 3,278 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$108 was the average price of a prescription from this provider, compared to $245 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
HYDROCODONE-ACETAMINOPHEN 483 200 S3 1 9
LEVETIRACETAM 370 103 2 3
GABAPENTIN 359 173 3 2
OXYCODONE HCL 331 71 S2 4 43
OXYCODONE HCL-ACETAMINOPHEN 330 80 S2 5 35
CARBIDOPA-LEVODOPA 270 212 6 1
DONEPEZIL HCL 260 208 7 4
PRIMIDONE 247 113 8 8
DIVALPROEX SODIUM ER 238 27 9 24
OXYCODONE-ACETAMINOPHEN 231 24 S2 10 33
BACLOFEN 221 54 11 11
NAMENDA 220 203 12 7
CARISOPRODOL 208 39 R 13 50
LYRICA 208 40 13 12
TOPIRAMATE 195 17 15 5
AMITRIPTYLINE HCL 183 52 R 16 18
CITALOPRAM HBR 168 92 17 16
CARBAMAZEPINE 161 12 18 20
OXCARBAZEPINE 160 32 19 15
TIZANIDINE HCL 159 19 20 13
CYCLOBENZAPRINE HCL 141 26 R 21 36
DICLOFENAC SODIUM 136 42 22 77
GALANTAMINE HBR 131 131 23 42
METHOCARBAMOL 129 28 R 24 54
PHENYTOIN SODIUM EXTENDED 125 50 25 14
AMANTADINE 118 71 26 26
LAMOTRIGINE 108 0 27 6
VENLAFAXINE HCL ER 108 73 27 61
ROPINIROLE HCL 106 66 29 10
SUMATRIPTAN SUCCINATE 105 11 30 38
QUETIAPINE FUMARATE 101 48 31 44
SULINDAC 100 13 32 122
CYMBALTA 99 47 33 27
TRAZODONE HCL 96 44 34 32
TRAMADOL HCL 91 28 35 29
MORPHINE SULFATE 90 0 S2 36 120
PAROXETINE HCL 85 34 37 97
OXAPROZIN 83 0 38 148
MAXALT 73 0 39 74
EXELON 73 62 39 22
MECLIZINE HCL 63 49 41 81
PROMETHAZINE HCL 60 0 R 42 56
SERTRALINE HCL 57 35 43 34
FLUDROCORTISONE ACETATE 56 19 44 98
MELOXICAM 55 17 45 67
ESCITALOPRAM OXALATE 55 15 45 66
ZOLPIDEM TARTRATE 55 18 45 28
CHLORZOXAZONE 51 0 R 48 127
PROPRANOLOL HCL 50 0 49 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.